Startseite>>Signaling Pathways>> GPCR/G protein>> mGluR >>VU0364770 hydrochloride

VU0364770 hydrochloride

Katalog-Nr.GC38597

VU0364770-Hydrochlorid ist ein selektiver und potenter positiver allosterischer Modulator (PAM) von mGlu4.

Products are for research use only. Not for human use. We do not sell to patients.

VU0364770 hydrochloride Chemische Struktur

Cas No.: 1414842-70-8

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
122,00 $
Auf Lager
1mg
41,00 $
Auf Lager
5mg
61,00 $
Auf Lager
10mg
92,00 $
Auf Lager
25mg
112,00 $
Auf Lager
50mg
204,00 $
Auf Lager
100mg
327,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

VU0364770 hydrochloride is a selective and potent positive allosteric modulator (PAM) of mGlu4. VU0346770 hydrochloride exhibits EC50s of 290 nM and 1.1 μM at rat mGlu4 and human mGlu4 receptor, respectively. VU0364770 hydrochloride exhibits antagonist activity at mGlu5 with a potency of 17.9 μM and PAM activity at mGlu6 with a potency of 6.8 μM. VU0364770 hydrochloride also possesses activity at MAO with Ki values of 8.5 and 0.72 μM for human MAO-A and human MAO-B, respectively[1].

[1]. Jones CK, et al. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. J Pharmacol Exp Ther. 2012 Feb;340(2):404-21.

Bewertungen

Review for VU0364770 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for VU0364770 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.